Teva goes to war with Eli Lilly over migraine breakthrough

07-02-2018

Teva goes to war with Eli Lilly over migraine breakthrough

mraoraor / iStockphoto.com

Teva sued Eli Lilly yesterday in a bid to protect its IP rights covering “breakthrough treatments for migraine headaches”.


Teva, Eli Lilly, biotech, biologic, migraine, patent infringement, patent, breakthrough,

LSIPR